Evidence map›Paper›PMID 41026812›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Mitochondrial ROS triggers mitophagy through activating the DNA damage response signaling pathway.

Qi-Qiang Guo, Shan-Shan Wang, Xiao-You Jiang, Xiao-Chen Xie, Yu Zou, Jing-Wei Liu, Yang Guo, Yu-Han Li, Xi-Yan Liu, Shuang Hao and 13 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Autoinflammatory syndromes of STING and TREX1 dysfunction.The Journal of clinical investigation · 2026
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Qi-Qiang Guo *The College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang 110122, Liaoning, China.ORCID 0000-0001-7905-7111
Shan-Shan Wang *The College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang 110122, Liaoning, China.ORCID 0009-0007-3697-8376
Xiao-You Jiang *The College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang 110122, Liaoning, China.ORCID 0009-0009-9339-9009
Xiao-Chen Xie *Department of Endocrinology and Metabolism, Institute of Endocrinology, National Health Commission of the People's Republic of China, Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Affiliated Hospital of China Medical University, Shenyang 110122, Liaoning, China.
Yu ZouThe College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang 110122, Liaoning, China.
Jing-Wei LiuThe College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang 110122, Liaoning, China.
Yang GuoThe College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang 110122, Liaoning, China.
Yu-Han LiThe College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang 110122, Liaoning, China.
Xi-Yan LiuThe College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang 110122, Liaoning, China.ORCID 0000-0003-1507-3643
Shuang HaoThe College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang 110122, Liaoning, China.
Xin-Yue ZhangThe College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang 110122, Liaoning, China.
Xiao-Xu WuThe College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang 110122, Liaoning, China.
Song-Ming LuThe College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang 110122, Liaoning, China.
Hong-De XuThe College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang 110122, Liaoning, China.
Wen-Dong GuoThe College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang 110122, Liaoning, China.
Yan-Ling FengThe College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang 110122, Liaoning, China.ORCID 0000-0001-8742-177X
Chuan-Gui WangThe Biomedical Translational Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255049, Shandong, China.
Sheng-Ping ZhangThe Biomedical Translational Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255049, Shandong, China.
Jia-Bin LiDepartment of Cell Biology, Key Laboratory of Cell Biology, National Health Commission of the People's Republic of China, Key Laboratory of Medical Cell Biology, Ministry of Education of the People's Republic of China, China Medical University, Shenyang 110122, Liaoning, China.
Chen LiuDepartment of Cell Biology, Key Laboratory of Cell Biology, National Health Commission of the People's Republic of China, Key Laboratory of Medical Cell Biology, Ministry of Education of the People's Republic of China, China Medical University, Shenyang 110122, Liaoning, China.
Xiao-Yu SongThe College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang 110122, Liaoning, China.ORCID 0000-0002-6606-327X
Toren FinkelAging Institute, University of Pittsburgh and University of Pittsburgh Medical Center, Pittsburgh, PA 15219.
Liu CaoThe College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang 110122, Liaoning, China.ORCID 0000-0001-6471-1993

Funding

Key Research Project of Liaoning 2021JH2/10300023Key Research Project of Liaoning 2022JH1/10400001Key Research Project of Liaoning 2022JH2/20200034Key Research Project of Liaoning 2022JH6/100100037Key Research Project of Liaoning 2024JH6/100800005MOST | National Natural Science Foundation of China (NSFC) 82030091MOST | National Natural Science Foundation of China (NSFC) 82073089MOST | National Natural Science Foundation of China (NSFC) 82102740MOST | National Natural Science Foundation of China (NSFC) 82370794Shenyang Youth Science and Technology Innovation Talent Support Program RC220139
6 · The paper itself

Abstract

The homeostatic link between the production of mitochondrial ROS (mtROS) and mitophagy plays a significant role in how cells respond to various physiological and pathological conditions. However, it remains unclear how cells translate oxidative stress signals into adaptive mitophagy responses. Here, we show that mtROS act as signaling molecules that activate the ataxia-telangiectasia mutated (ATM)-cell cycle checkpoint kinase 2 (CHK2), a DNA damage response (DDR) pathway. When activated, CHK2 regulates three critical steps in mitophagy. First, CHK2 phosphorylates mitochondrial membrane protein ATAD3A at Ser371, which inhibits the transport of PINK1 to the inner mitochondrial membrane and leads to the accumulation of PINK1 and the commencement of mitophagy. Second, activated CHK2 targets the autophagy adaptor OPTN at Ser177 and Ser473, thereby enhancing the targeting of ubiquitinated mitochondria to autophagosomes. Finally, CHK2 phosphorylates Beclin 1 at Ser90 and Ser93, hence promoting the formation of autophagosomal membranes. Consistent with these effects,

Indexed as

DNA DamageMitochondriaMitophagyReactive Oxygen SpeciesSignal TransductionAnimalsAtaxia Telangiectasia Mutated ProteinsAutophagyBeclin-1Checkpoint Kinase 2HumansMembrane ProteinsMiceMice, KnockoutMitochondrial ProteinsOxidative StressAtaxia Telangiectasia Mutated ProteinsBeclin-1Checkpoint Kinase 2Chek2 protein, mouseMembrane ProteinsMitochondrial ProteinsProtein KinasesPTEN-Induced Putative KinaseReactive Oxygen SpeciesATMCHK2mitophagymtROSPINK1

Identifiers

PMID41026812
PMCPMC12519191

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.